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Abstract
Background: Menopause is characterized by a decrease in life quality due to the appearance of uncomfortable
symptoms. Nowadays, Understanding menopause-associated pathophysiology and developing new strategies to
improve the treatment of menopausal-associated symptoms is an important issue. Our study was to evaluate the
synergistic effects of Danshen (salvia miltiorrhiza bunge) and the phytoestrogenic effects of 3 modified Qing E
formulas, to explore a better formula for menopausal disorders.
Methods: 100 rats were randomized into 5 groups: Sham (Sham operation group), OVX (model group of
ovariectomized rat), BDL (group with low concentration of Qing E Formula), BDH (group with high concentration
of Qing E Formula) and BDD (group with high concentration of Qing E Formula Plus Danshen), receiving vehicle
and extract of different modified Qing E formula respectively. The food intake, body weight, uterus weight,
blood levels of triglycerides (TG), total cholesterol (TC) and cholesterol fractions were assessed. The mammary
glands and uterus were morphologically analyzed. The bone density of tibias were measured by peripheral
quantitative computed tomography (pQCT). Additionally, luciferase induction assays were performed in Hela
cells with the mixtures derived from Qing E formula plus Danshen (BDD).
Results: Qing E formula plus Danshen significantly increased the uterus wet weight, enhanced the thickness of
uterine wall, endometrial epithelium and glandular epithelium, improved trabecular bone and total density
evidently, reduced the levels of low density lipoprotein cholesterol (LDL-C) and TG, possessed notable estrogen
receptor beta (ERβ) and estrogen receptor alpha (ERα) agonist activity.
Conclusion: Qing E formula plus Danshen exerted more evident estrogen-like effects, thus it has a potential
therapeutic use to treat menopausal disorders.
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Background
Menopause is characterized by an altered hormonal status
and by a decrease in life quality due to the appearance of
uncomfortable symptoms. Nowadays, with increasing life
span, women spend one-third of their lifetime under meno-
pause. Understanding menopause-associated pathophysi-
ology and developing new strategies to improve the
treatment of menopausal-associated symptoms is an
important topic in clinics [1]. Hormone-replacement
therapy (HRT) or estrogen-replacement therapy (ERT) is
recommended for postmenopausal women primarily for re-
duction of menopausal symptoms and prevention of osteo-
porosis and cardiovascular disease. However, the treatment
with estrogens after menopause may include a potential
increase in the risk of breast cancer (relative risk seems to
be about 1.3 after at least 8 years of HRT) [2], an increase
in vaginal bleeding and an increased risk of endometrial
cancer [3, 4]. Because of this, there is increasing interest
in the use of plant-derived estrogens, also known as
phytoestrogens.
Phytoestrogen is present in a wide variety of plant
products, especially tonic and blood-activating Chinese
herbs, with many categories of ingredients including
lignans, isoflavonoids, coumestans and resorcyclic acid
lactones, all of which bind estrogen receptors, but a
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lower binding affinity than steroidal estrogens. Phyto-
estrogen exerts estrogenic and/or anti-estrogenic effects
inherently or after being conversed by intestinal flora
against menopausal symptoms and a variety of disorders,
including hot flushes, cardiovascular disease, cancer,
hyperlipidemia, osteoporosis, and various forms of
chronic renal disease, without serious side effects [5].
In China, Qing E Wan is one of the most well-known
Herbal formulas, which was published in “Taiping Hui
Min He Ji Ju Fang” in Song Dynasty (about year 1148),
and composed of 4 kinds of herbs: Duzhong (eucommia
bark), Buguzhi (psoralea corylifolia), walnut meat and gar-
lic. Qing E Wan is also used medicinally in Pharmacopoeia
of the People's Republic of China (year 2005) to relieve
back pain, increase stamina, make bones and muscles
'strong' and to hasten recovery from fatigue, which are fe-
male hormone-related pharmacological effects. But all the
herbs in Qing E Wan are hot-natured that is only suitable
for kidney-yang deficiency (cold syndrome) patients ac-
cording to Traditional Chinese Medicine (TCM).
In our research, only the two main herbs, Duzhong and
Buguzhi, of Qing E Wan were left, and named as Qing E
Fomula (BDL & BDH groups). For improving Qing E Wan
to be more suitable for general patients (including heat
syndrome) and the pathogenesis of menopause—kidney
deficiency and blood stasis [6], a traditional Chinese herbal
medicine, Danshen, was added into another research group
named as Qing E formula plus Danshen (BDD).
The present study was conducted in order to evaluate
the synergistic effects of Danshen and the estrogenic ef-
fects of 3 modified Qing E formulas, by oral gavages in
the ovariectomized rats models of menopause and lucif-
erase induction assays in Hela cells, to explore a better
formula for the menopausal treatment.
Methods
Experimental animals
Postpartum female Sprague–Dawley rats (6-month-old,
weighting 270士50g) were purchased from Shanchuan-
hong laboratory animals technology co. ltd, Tianjin, China
(license No. SCXk 2009–0001). All rats were housed at
the Experimental Animal Center, Tianjin University of
Traditional Chinese Medicine (TJUTCM), on sawdust in
the plastic bottomed cages at 22–24 °C under a 12 h
light–dark cycle, and were provided with rodent chow and
tap water ad libitum. All procedures were approved by the
Animal Care and Use Committee of TJUTCM and con-
form to the Guide for the Care and Use of Laboratory
Animals published by the U.S. National Institutes of
Health (NIH Publication number 85–23, revised 1996).
Herbs
The herbs of Buguzhi, Duzhong and Danshen were pro-
vided by Institute of Traditional Chinese Medicine,
TJUTCM. Drug lot numbers were: 20090620. The extracts
of Buguzhi, Duzhong and Danshen were prepared by
pharmacist Liu and Wang in the above institute. The ex-
traction rates of Buguzhi, Duzhong and Danshen are 20,
12 and 52.6 % respectively. The essential components of
Buguzhi are bakuchiol and flavones; Duzhong’s are flavones,
iridoid and lignans; Danshen’s are tanshinones and salvia-
nolic acids. The dried herbal extractions were immersed
into boiling water with 10 ml of 0.3 % carboxymethylcellu-
lose sodium solution for 30 min each group. Then the
water solution was stored at 4 °C for administration.
Grouping of animals and herbal administration
One hundred rats were verified at normal estrus stage
with vaginal smear and Papanicolaou (PAP) staining [7]
after 10 days’ acclimation. Then all were anesthetized
with chloral hydrate (3 ml/kg, TCI, China). Of these ani-
mals, 20 underwent a sham operation (sham group),
while 80 were bilaterally ovariectomized (OVX).
Two weeks later, the OVX rats were randomized into
four groups of twenty animals each (OVX group, BDL
group, BDH group and BDD group). The sham and
OVX model groups received vehicle (0.3 % of carboxy-
methylcellulose sodium solution and purified water).
The BDL and BDH groups received low- and high-dose
extract of modified Qing E formula at the human equiva-
lent dose of 250 and 500 mg/kg/day, respectively. The
BDD group received high-dose extract of Qing E formula
plus Danshen at dose of 1815 mg/kg/day. The details are
as follows:
In humans, the clinical dosages of Buguzhi, Duzhong
and Danshen are respectively about 4 g/day, 10 g/day
and 10 g/day of dried herb recorded in the Chinese
Medicine textbook. Considering the average body weight
of an adult as 60 kg, to convert the human dose to rat
dose equivalent, the amounts would be 0.42 g/kg/day,
1.05 g/kg/day and 1.05 g/kg/day (4 g/day/60 kg × 6.3,
10 g/day/60 kg × 6.3 and 10 g/day/60 kg × 6.3,) according
to van Miert [8]. The total dosage of Buguzhi and Duz-
hong was 1.47 g/kg/day (0.42 + 1.05) for rats. Since very
notable uterotrophic effect wasn’t shown up by using
1.47 g/kg/day of Buguzhi and Duzhong in the pre-test.
So the herbs was lightly increased to 1.75 g/kg/day
(0.5 g/kg/day of Buguzhi and 1.25 g/kg/day of Duzhong)
as group BDL in this research. The BDH was 3.5 g/kg/
day (2 times of BDL); BDD was 6 g/kg/day (2 times of
BDL plus Danshen, the amount of Danshen was equal to
Duzhong). The extract yields of Buguzhi, Duzhong and
Danshen were 20.0, 12.0 and 52.6 % of the raw material
respectively. Therefore, the extract amounts of BDL,
BDH and BDD were 0.25 g/kg/day (0.5 g/kg/day × 20 % +
1.25 g/kg/day × 12 %), 0.5 g/kg/day (2 times of BDL) and
1.815 g/kg/day (2 times of BDL plus Danshen = 0.5 g/kg/
day +2.5 g/kg/day × 52.6 %).
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Half of animals were administrated for 6 weeks, the
other half for 12 weeks by oral gavages in a volume of
10 ml/kg. Their body weight and food intake were weekly
recorded throughout the whole experiment period.
Serum and organ collection
After 6 weeks of treatment, half of animals were sub-
jected to overnight fasting, then weighed and sacrificed
under chloral hydrate (3 ml/kg, TCI, China) anesthesia
between 8:00 and 12:00. Their blood was collected from
the abdominal aorta into polypropylene tubes and kept
at 4 °C for 2–4 h. The serum was obtained after centri-
fugation of these blood samples at 3000 rpm for 15 min
at a temperature of 4 °C, then aliquoted in quadruplets
into 2 ml polypropylene tubes and stored at −20 °C until
further analysis.
The fifth mammary glands were collected and stored
in 10 % buffered formalin for histopathologic examin-
ation and assessment of epithelial proliferation. The ab-
dominal cavity was opened with a longitudinal cut and
the uteri were removed. These uterine horns were dis-
sected free of adhering fat and mesentery. After weigh-
ing, one uterine horn was fixed in 10 % buffered
formalin for histological evaluation; The contralateral
horn was transferred into 2 ml polypropylene tubes, fro-
zen in liquid nitrogen, then stored at −80 °C for further
analysis.
Twelve weeks later, the rest of rats were sacrificed
under chloral hydrate (3 ml/kg, TCI, China) anesthesia.
Their right tibias were dissected out, cleaned away all
the soft tissues, placed in 70 % ethanol and stored at 4 °C
for scanning by pQCT.
Blood lipid test
The TG, TC, serum high density lipoprotein cholesterol
(HDL-C), and LDL-C levels were measured by standard
colorimetric methods using a semi-automatic biochemical
analyzer type Microlab 300 (Vital Scientific, Netherlands).
The kits were purchased from Zhongsheng Beikong Bio-
technology and Science Inc. (Beijing, China).
Gonadal hormone test
The rest of serum samples were taken to the Clinical
Laboratory of Tianjin Medical University General Hos-
pital, where the serum 17β-estradiol, follicle-stimulating
hormone (FSH) and luteinizing hormone (LH) were de-
termined using the radioimmunoassay kit supplied by
DSL co., Czech.
Mammary gland and uterine histology
All the formalin-fixed mammary glands and uterine horns
were embedded in paraffin, cut into 4-mm thick slices, and
stained with hematoxylin-eosin (H&E) for morphological
analysis. The histological structure changes were observed
under a light microscope, including the morphology and
polarity of epitheliums, the thickness of uterine wall and
endomembrane, the height of glandular epithelium and
endometrium epithelium. Then, the color photographs
were collected under a medical digital image acquisition
system (Soft Imaging System, Munster, Germany).
Estrogenic activities test
To investigate the estrogenic activities of the mixtures
derived from Qing E formula plus Danshen (BDD), lucif-
erase induction assays were performed in Hela cells.
Hela cells were cultured as described previously [9].
Mammalian expression vectors, ERαand ERβ, were gifts
from Dr. Karas (Tufts Medical Center, Boston, USA). The
luciferase reporter plasmid, carrying 3 × vitellogenin ERE
(estrogen response element, ERE), was kindly provided by
Dr. J. Zhang (Nankai University, Tianjin, China). Cells
were plated, in triplicate, in 24- well plates at a density of
2 × 105 cells/well in 10 % CD-FBS. After attachment and
growth for 24 h, the cells were cotransfected with the re-
porter plasmid ERE-TK-Luc and ERα/β expression plas-
mids. pRL-TK plasmid, which contains a Renilla luciferase
gene, was used as a control for normalising transfection
efficiency. Transfection was carried out for 18 h in serum-
free, antibiotic-free DMEM media, using Lipofectamine
2000 (Invitrogen/Life Technologies, Carlsbad, CA) ac-
cording to the manufacturer’s instructions; medium was
removed, Hela cells were treated with various drug con-
centrations of aqueous extract from Qing E formula plus
Danshen (0.1, 1, 10, 100 μg/ml, respectively), and incu-
bated for 24 h following transfection. E2 (10 nM) was used
as positive control. The cells from each well were lysed.
Aliquots from each well were divided into two 96-well
plates for luciferase and Renilla activity determination
using a Topcount NXT luminescence counter (Packard
Instrument Company, Meriden, CT). Experiments were
performed at least three times and the data were assessed
as units of firefly luciferase activities normalised to the
Renilla luciferase control activities from individual wells.
pQCT measurements
All the ethanol-fixed tibias were posted to Shanghai In-
stitute of Materia Medica,Chinese Academy of Sciences,-
for BMD analysis using a pQCT apparatus (Stratec XCT
Research SA, Stratec Medizintechnik GmbH, Pforzheim,
Germany). The modalities of proximal tibias were dis-
play by vertical scanning. Then the tibias of epiphyseal
line down to 3.0 mm (containing a high percentage of
trabecular structure) and 12.0 mm (mainly cortical struc-
ture) were faulting scanned using a 0.46-mm collimation
(4 × 105counts/s) and a 0.08-mm voxel size. Thresholds
for segmentation of trabecular and cortical bone were set
at 300 mg/cm3 and 900 mg/cm3, respectively.
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Statistical analysis
All statistical analysis was performed by using Statistical
package for the Social Sciences (version 16.0; SPSS, Inc.,
Chicago, IL, USA). The analysis of variance (ANOVA),
Post-hoc Bonferroni test, and paired t test were used to
evaluate the effects of each variable and to reveal the statis-
tical significance. P value <0.05 was considered significant.
Results
Effects on the food intake, body weight and uterus weight
Rats in all experimental groups had similar initial body
weights and similar food intake. All the body weights in-
creased continuously during the research. In the OVX
group, the body weight gains showed notable increase
(Table 1), and BDH group was significant increase also.
As expected, ovariectomy induced obvious uterus atro-
phy and the decreased uterus index. But the uterus wet
weight in BDD group showed significant increasecom-
pared with the OVX group.
Effects on the blood lipid
Table 2 shows a significant increase in serum TC, LDL-C,
HDL-C and TG in OVX group compared with sham
group. Administrating the 3 formulas to OVX rats resulted
in a significant reduction in the LDL-C, and TG levels
compared with OVX rats. In terms of serum TC, no statis-
tically significant difference was seen among the three
treated groups. Although HDL-C levels of all the OVX rats
were still higher than the sham group’s, HDL-C/TC were
significantly increased in BDH and BDD group.
Effects on the gonadal hormones
Ovariectomied rats showed significant increase in FSH
and LH, but notable decrease in E2 (Table 3). After ad-
ministration of the 3 formulas, E2 was mildly increased
in each treated group. As for FSH and LH, no statisti-
cally significant difference was observed.
Effects on the morphology of mammary and uterine tissue
Figure 1 shows the microscopic preparations of repre-
sentative mammary glands from one animal per treat-
ment group. In the sham group, the structure of
mammary glands were normal. The alveoli and ducts of
mammary gland were simple cuboidal epithelium or col-
umnar epithelium with larger cell size, round or oval nu-
clei. In the OVX group, the mammary glands were
severely atrophied. The alveoli and ducts of mammary
gland were made up of low-cube-shaped epithelium with
smaller cell size and shrunk nuclei. However, in all 3
treatment groups, the mammary glands showed different
degrees of slighter atrophy in comparison with the OVX
group. But the alveoli and ducts of mammary gland were
still simple cuboidal epithelium. Figure 2 shows micro-
scopic preparations of representative uteri from one ani-
mal in each treatment group. The quantitative data
obtained from uterine tissues of all animals are shown in
Table 4. Every uterus tissue morphology in the sham
group was normal. But in the OVX, uterus atrophy was
observed in all structures. The endometrium was com-
posed of inactive cuboidal cells, and the connective tis-
sue was an unorganized lax syncytium with contracted
nuclei. The quantity of endometrial glands in subintima
was decreased. Simultaneously, the size and glandular
cavity of glands were shrunken. While slight atrophy of
uterus was observed in all formula treated groups. The
glandular epithelium thickness showed obvious differ-
ence at various degrees in all formula treatment groups
in comparison with the OVX. Additionally, and the
thickness of uterine wall and endometrial epithelium
also showed significant increase in the BDD group com-
pared with the OVX.
Effects on the BMD
From the data and images of cancellous bone in the
proximal tibial metaphysis (the epiphyseal line down to
3.0 mm) scanned by pQCT (Figs. 3 and 4), it was clearly
seen that ovariectomy resulted in the reduction of tra-
becular bone and total density. However, those were
significantly improved by Qing E formula Plus Danshen.
But no apparent difference was observed at the epiphys-
eal line down to 12.0 mm.
Effects on the expression of estrogenic activities
E2 and the mixtures from Qing E formula plus Danshen
(BDD) did increase luciferase activity for ERs. The
Table 1 Effects on the food intake, body weight and uterus weight












Sham (n = 9) 30.01 ± 5.61 265.11 ± 31.07 284.67 ± 43.85 19.56 ± 4.83 0.566 ± 0.13 0.2124 ± 0.05
OVX (n = 8) 30.60 ± 5.63 255.75 ± 35.03 302.25 ± 49.40 46.50 ± 7.08** 0.176 ± 0.03** 0.0641 ± 0.022**
BDL (n = 9) 27.83 ± 6.26 253.11 ± 25.95 288.11 ± 34.52 35.00 ± 8.77 0.193 ± 0.03** 0.0720 ± 0.02**
BDH (n = 9) 27.82 ± 3.24 245.56 ± 24.96 282.67 ± 29.21 38.22 ± 5.10* 0.204 ± 0.03** 0.0776 ± 0.01**
BDD (n = 9) 28.80 ± 6.06 260.63 ± 53.64 289.13 ± 50.76 28.50 ± 4.63 0.211 ± 0.03**▲ 0.078 ± 0.01**
Data are expressed as mean ± S.E.M. Means in columns with superscript are significantly different. *P < 0.05,**P < 0.01 vs. Sham group; ▲P < 0.05 vs. OVX
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mixtures at varying mass concentrations (0.1, 1, 10,
100 μg/ml, respectively) all caused a significant increase
of luciferase activity in ERα, while at these concentra-
tions (1, 10, 100 μg/ml, respectively) caused a significant
increase of luciferase activity in ERβ, both in a dose-
dependent manner. When the potencies were compared,
it was evident that none of the mixtures was more po-
tent than E2 in ERα, but the mixture at the concentra-
tion of 100 μg/ml showed noticeably more potent than
E2 in ERβ. When the cells were simultaneously treated
with the test mixture and a pure ER antagonist, ICI
182,780, at a concentration of 1 μg/ml, luciferase activity
was greatly suppressed. The test mixtures transactivated
better through ERβ than ERα (Fig. 5).
Discussion
Menopause leads to a wide range of symptoms and dis-
orders, including hot flashes, night sweats, sleeping
problems, emotional dysfunction, endocrine disorders
including hyperlipidemia, hypertension, hyperglycemia,
and osteoporosis etc.. Phytoestrogens have been applied
for compensation of hormone deficiency in the meno-
pause [10]. Phytoestrogens are present in certain edible
plants being most abundant in soy; they are structurally
and functionally analogous to the estrogens. Among
them, isoflavones and coumestans are the most exten-
sively studied groups. Isoflavones are present in different
edible plants being most abundant in soy [11–13]. How-
ever, soy is known as allergenic food at least for some
populations [12, 14]. In regard to osteoporosis, the latest
review concluded that ‘evidence points to a lack of a
protective role of soy isoflavones in the prevention of
postmenopausal bone loss’ [15]; Dewell’s findings sug-
gested that soy-derived phytoestrogens did not signifi-
cantly alter serum lipoproteins in postmenopausal
women and, therefore, might not effectively reduce the
risk of Coronary Artery Disease [16]. As for other phy-
toestrogens, in animals, the intake of clover was reported
to impact fertility and morphogenesis of ovaries in sheep
[17]. Therefore, we are still on the way to seek more
effective phytoestrogens for menopausal treatment.
According to the TCM theory, the pathogenesis of
menopause is kidney deficiency and blood stasis. Kidney
deficiency is the fundamental pathogenesis. Therefore,
we kept looking for the most proper formula specialized
in nourishing kidney and promoting blood circulation.
Qing E Wan has been already used as an important for-
mula for treating postmenopausal osteoporosis in Chin-
ese traditional medicine. For improving it to be more
suitable for menopausal treatment, Danshen was added
in a research group. Qing E formula plus Danshen is
composed of Duzhong, Buguzhi and Danshen, which are
all well-known traditional Chinese medicine and applied
in clinic for thousands years. In this formula, Duzhong
and Buguzhi are the principal herbs. Duzhong is the bark
of the Chinese medicinal herb, Eucommia ulmoides
Oliv., warm in nature, playing an important role in nour-
ishing the liver and kidney, strengthening bone and
muscle, and preventing abortion etc. [18–20]. Buguzhi is
the seed of psoralea corylifolia L., warm in nature, effica-
cious in warming kidney yang and antidiarrheal. It has
been applied as a tonic or an aphrodisiac agent and
commonly used as a remedy for bone fracture, osteomal-
acia and osteoporosis in China [21]. A in vitro research
also demonstrated that Buguzhi exhibited osteoblastic
proliferation stimulating activity in UMR106 cell line
cultured, and might stimulate bone formation or have
potential activity against osteoporosis [22]. Danshen is
the root of Salvia miltiorrhiza bunge, considered to have
an action of quickening the blood and dispelling stasis,
and is frequently used to treat related disorders of blood
stasis such as cerebrovascular accident and ischemic
heart disease [23]. It has been reported to have an anti-
platelet aggregation effect [24], and support bone heal-
ing [25]. Additionally, Danshen, Buguzhi, Duzhong and
Table 2 Effects on the blood lipid
Groups TG (mmol/l) TC (mmol/l) HDL-C (mmol/l) LDL-C (mmol/l) HDL-C/TC (%)
Sham (n = 9) 0.772 ± 0.10 2.406 ± 0.18 0.884 ± 0.05 0.414 ± 0.05 37.23 ± 3.48
OVX (n = 8) 1.644 ± 0.31** 2.931 ± 0.22* 1.046 ± 0.04** 0.676 ± 0.13** 36.34 ± 4.01
BDL (n = 9) 1.006 ± 0.15▲▲** 2.824 ± 0.18 1.078 ± 0.05** 0.396 ± 0.06▲▲ 38.46 ± 2.44
BDH (n = 9) 0.666 ± 0.03▲▲ 2.682 ± 0.06 1.131 ± 0.03** 0.411 ± 0.04▲▲ 42.18 ± 2.19▲▲*●
BDD (n = 9) 0.478 ± 0.02▲▲● 2.757 ± 0.10 1.095 ± 0.02** 0.399 ± 0.02▲▲ 39.93 ± 2.67▲
Data are expressed as mean_S.E.M. Means in columns with superscript are significantly different. *P < 0.05,**P < 0.01vs. Sham group; ▲P < 0.05,▲▲P < 0.01 vs. OVX
group; ●P < 0.05 vs. BDL. TG triglyceride, TC total cholesterol, HDL-C high density lipoprotein cholesferol, LDL-C low density lipoprotein cholesferol
Table 3 Effects on the gonadal hormones
Groups FSH (ng/ml) LH (ng/ml) E2 (pg/ml)
Sham (n = 9) 5.86 ± 0.77 0.38 ± 0.03 14.05 ± 1.09
OVX (n = 8) 51.40 ± 5.82** 4.22 ± 0.36** 8.26 ± 0.76**
BDL (n = 9) 45.81 ± 4.20** 4.64 ± 0.61** 10.40 ± 0.98*
BDH (n = 9) 53.01 ± 5.25** 3.81 ± 0.34** 10.83 ± 1.46*
BDD (n = 9) 51.11 ± 4.10** 4.71 ± 0.38** 10.87 ± 0.87*
Data are expressed as mean_S.E.M. Means in columns with superscript are
significantly different. *P < 0.05,**P < 0.01vs. Sham group; FSH follicle-
stimulating hormone, LH luteinizing hormone, E2 estradiol
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Danshen were also confirmed to possess estrogenic ac-
tivity respectively [26–28]. Therefore, we assumed that
Danshen could enhance the estrogenic effects of Qing E
formula.
Studies on rodent and non-human primates rely on an
ovariectomized model of surgical menopause, resulting in
abrupt withdrawal of estrogen. The uterus is one of the
major target tissues of endogenous and exogenous estro-
gens [29]. Our study demonstrated that ovariectomized
rats showed a significant decrease in serum estrogen con-
centration (Table 3), uterine wet weight (Table 1) and
endometrial thickness (Table 4) compared with sham-
Fig. 1 Effects on the morphology of mammary. The longitudinal section of the mammary in each group. After the administration of 3 modified
Qing E formulas, the mammary glands showed different degrees of slighter atrophy in comparison with the OVX group
Fig. 2 Effects on the morphology of uterine tissue. A1-A5 showed the transverse section of the uterus in each group. The endometrium thickness
of all the ovariectomized rats was significantly decreased compared with the sham group, but mildly increased by all the formulas. Redline - the
endometrium. (100×). B1-B5 showed transverse section of the uterus in each group. The endometrium epithelium thickness of all the ovariectomized
rats was significantly decreased compared with the sham group, But significantly increased by Qing E formula plus Danshen. Arrow- epithelium. (400×).
C1-C5 showed transverse section of the uterus in each group. The uterine glandular epithelium thickness of all the ovariectomized rats was significantly
decreased compared with the sham group, But significantly increased by all the formulas. Arrow-uterine gland. (400×)
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operated rats. The reduction in endometrial thickness was
caused by the lack of estrogen secreted by the ovaries. Ad-
ministration of three Qing E formulas to ovariectomized
rats for 6 weeks slightly increased serum estrogen concen-
tration, uterine wet weight and endometrial thickness.
However, Qing E formula plus Danshen increased the Uter-
ine wet weight significantly (Table 1) compared with low
dose and high dose of Qing E formula., which was due to
the notably increased thickness of uterine wall, endometrial
epithelium and glandular epithelium (Table 4; Fig. 2). But
no obvious overstimulation was observed in the morph-
ology of mammary and uterine tissue (Figs. 1 and 2).
Therefore, Danshen enhanced the estrogenic effects of
Qing E formula. In another word, Qing E formula plus
Danshen could be considered a safe and more effective
complementary or alternative treatment for menopausal
syndrome.
For identifying the estrogenic activities of Qing E plus
Danshen, we assessed the effects of Qing E plus Danshen
on ERα alone and ERβ alone in HeLa cells after in vitro re-
search. It has been proposed that tissue-specific estrogenic
and/or antiestrogenic actions of certain xenoestrogens may
be associated with alterations in the tertiary structure of
ERα and/or ERβ following ligand binding. ERα is the pre-
dominant ER found in uterus and liver, whereas ERβ is
highly expressed and is almost the exclusive ER in ovarian
granulosa cells [30]. The presence of ERα is associated with
the proliferative effects of estrogens, whereas the bulk of
current evidence implies that ERβ as growth suppressive
properties [31], selective activation of ERβ in cells may
serve to suppress growth of estrogen-dependent cells. In
our research (Fig. 5), Qing E formula plus Danshen en-
hanced luciferase activity of ERs in transiently transfected
Hela cells. None of the Qing E formula plus Danshen was
more potent than E2 in ERα, but the mixture at the con-
centration of 100 μg/ml showed noticeably more potent
than E2 in ERβ. Meanwhile, the increase of estrogenic ac-
tivities was obviously inhibited by ICI 182,780, an estrogen
receptor antagonist. These results demonstrated that Qing
E formula plus Danshen possesses significant estrogen-like
activity with ERβ and ERα agonist activity, and a slightly
higher affinity for ERβ in HeLa cells. This is in agreement
with a previous study report that traditional Chinese herb
contains compounds that could be considered to be poten-
tial selective estrogen receptor modulators (SERMs) with
specific agonist estrogenic activity [32, 33].
Postmenopausal osteoporosis is one of the major types of
osteoporosis in humans. Animal models for postmeno-
pausal osteoporosis are generated by ovariectomy. Morni-
toring of BMD is important for diagnosis and the treatment
Table 4 Uterine tissue morphology
Groups Uterine wall thickness (μm) Endometrium thickness (μm) Endometrial epithelial thickness (μm) Glandular epithelium thickness (μm)
Sham (n = 9) 1397.2 ± 232.7 492.2 ± 214.66 31.15 ± 9.62 59.18 ± 14.03
OVX (n = 8) 732.9 ± 158.9** 289.7 ± 86.9** 25.16 ± 5.04* 31.44 ± 6.59**
BDL (n = 9) 750.3 ± 171.5** 337.9 ± 108.9** 24.44 ± 4.25* 45.97 ± 10.94*▲
BDH (n = 9) 774.6 ± 210.5** 321.4 ± 87.3** 24.20 ± 2.24* 47.92 ± 11.75*▲▲
BDD (n = 9) 907.4 ± 71.2**▲ 343.3 ± 68.53** 31.03 ± 5.55▲ 43.57 ± 8.88**▲
*P < 0.05,**P < 0.01vs. Sham group; ▲P < 0.05,▲▲P < 0.01 vs. OVX group
Fig. 3 Effects on the BMD. a showed that the density of trabecular bone and total bone density were significantly improved by Qing E formula
Plus Danshen at epiphyseal line down to 3.0 mm; b showed that there was no apparent difference shown at the epiphyseal line down to 12.0
mm. ★P < 0.05 vs. Sham group; ▲▲P < 0.01 vs. OVX group; #P < 0.05 vs. BDH group
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of osteoporosis as decreased bone mass is a major charac-
teristic of this disease. In this study, decreased BMD in
OVX rats, determined by pQCT, was observed only in the
metaphysic of tibia, trabecular bone, which contains osteo-
blasts and osteoclast on its surface and is more active in
bone turnover and bone remodeling compared to cortical
bone [34, 35]. Indeed, our analysis of OVX rats showed
only loss of trabecular BMD.at the epiphyseal line down to
3.0 mm, but it was very significantly improved after 12-
week oral administration of Qing E formula plus Danshen
(Figs. 3 and 4). In other words, the density of cancellous
bone proximal epiphysis line was improved significantly.
This finding is consistent with previous studies that the loss
of bone in adult OVX rats was more prominent in trabecu-
lar than cortical bone [36], and phytoestrogens have been
implicated in the prevention of bone loss in postmenopausal
Fig. 4 Tomographic determination of BMD scanned by pQCT (3.0 mm & 12.0 mm down to the epiphyseal line of proximal tibia). The scale bar of
BMD is from 0 to over 1000 shown at the left with color variation from black, gray, red, blue,…to white. In Fig. 4-a, there was evidently higher
intensity component with red and blue signal values in the cancellous bone area in group BDD comparing to OVX, which was mostly in gray;
however, the BMD of cortical bone didn’t show any notable difference in fig. 4-b.
Fig. 5 Effects on the expression of estrogenic activities. Transcription of ERα and ERβ activated by the mixture of BDD in Hela cells. Hela cells
were transiently cotransfected with pERE-luc, pRL-TK, and ERα or ERβ by lipofection. The cells received no treatment, treatment with 10 nM E2, or
treatment with varying mass concentrations of each of the mixture alone. Estrogen-stimulated luciferase activity of ERs was measured and the
data was presented as the fold-increase over control + standard deviation, and fold-increase representative of three experiments done in triplicate.
** P < 0.01 vs. control; ◆◆P < 0.01 vs.E2
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osteoporosis [37]. The integrity of skeletal is maintained
through a bone remodeling process that balances bone
formation and bone resorption [38]. Bone loss occurs in
estrogen deficiency due to enhanced bone resorption and
impaired osteoblast function. phytoestrogen provides a
protective effect against OVX-induced bone loss that is as-
sociated with decreased bone turnover through suppress-
ing bone resorption. ERα induces osteoclast apoptosis, but
the mechanism for impaired osteoblast function remains
to be clarified [39]. The improvement in BMD following
Qing E formula plus Danshen treatment may be partly at-
tributed to its estrogenic activity (Fig. 5), and evidenced by
increased uterine weight in Qing E formula plus Danshen
exposed animals (Table 1), which is consistent with the
report that Danshen is supporting bone healing [25].
Sex hormones strongly influence body fat distribution
[40]. Ovariectomy-induced obesity has been attributed
to metabolic changes as a result of ovarian hormone
deficiency, which leads to increased fat synthesis and
deposition in the adipocytes. When adipocytes reach
their capacity of fat storage, fat becomes mobilized to be
deposited in the viscera as the skeletal muscles, heart
and liver (ectopic fat syndrome) [41]. That is frequently
associated cardiovascular risk factors (dyslipidemia,
atherosclerosis, and coronary artery disease). Our data
showed a significant increase in the body weight of ovar-
iectomised rats compared with the sham, although their
food consumption was comparable throughout the study
(Table 1). The increased body fat was either due to in-
creased lipogenesis or decreased lipolysis or both [42].
In the present research, the ovariectomised rats showed
significant increases in their TG and TC levels, particu-
larly in the LDL fraction (Table 4). After 6-week oral ad-
ministration of all 3 formulas to the OVX rats, LDL-C
and TG levels were significantly reduced, but HDL-C/
TC level was remarkably increased compared with the
OVX rats. This indicated that all the Qing E formulas
have evident beneficial effects on improving serum lipids
to potentially reduce the risk of coronary heart disease
with a dose-dependent effect and synergistic effect with
Danshen. This is consistent with the report that phytoes-
trogens may contribute to the decreased incidence of
postmenopausal cardiovascular disease [43].
All the data demonstrated that Danshen has the notable
synergistic effect on promoting the estrogenic activities of
Qing E formula. This verified the rationality of TCM
cognition in menopausal pathogenesis: kidney deficiency
and blood stasis. According to TCM, the effect of Duzhong
and Buguzhi is to tonify the kidney, Danshen is to improve
the blood circulation. Therefore, Qing E formula plus
Danshen hits the pathogenesis, and it is more effective in
treating menopausal disorders holistically. This is also why
TCM aims toward healing rather than symptomatic
treatment.
Although the results are encouraging, This study was
the most preliminary research for Qing E formula plus
Danshen. we had some shortness, eg. the medicinal
mechanism was not very clear. So we still have a long
way to go. In the following research, we will increase the
quantity of rat samples, verify whether the effects of
Qing E formula plus Danshen on bone mineral densities
are adjusted by ERs, and investigate how the formula
affects the metabolism of osteoblasts and osteoclast, to
elucidate the underlying mechanisms more clearly.
Conclusion
Qing E formula plus Danshen exerted more evident estro-
genic effects than other groups in improving the structure
of estrogen target organs such as uterus and bone, and
modulating endocrine metabolism. These effects may be
attributed to an alteration in gene expression of ERs mod-
ulated by the formula. Thus, Qing E formula plus Danshen
has demonstrated a potential therapeutic use in the treat-
ment of menopausal disorders.
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